New Findings from Zhejiang Provincial People's Hospital in the Area of Brain Injury Published [Efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) versus piracetam on cognition and functional outcomes for adults...].

A new study conducted at Zhejiang Provincial People's Hospital in Hangzhou, China, explores the efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) compared to piracetam in improving cognitive and functional outcomes for adults with traumatic brain injury (TBI). The study aims to recruit 900 adult patients with mild to moderate TBI and will be a multicenter, randomized, double-blind trial. The primary outcome will be the change in the Montreal Cognitive Assessment (MoCA) score after 3 months, with secondary outcome measures including Mini-Mental State Examination (MMSE) scores, Glasgow Outcome Scale-Extended (GOS-E), and the Barthel Index. The trial aims to provide high-quality evidence on the effectiveness of CPCGI in improving outcomes for TBI patients. [Extracted from the article]